Page results
-
This page provides information about the sclerotherapy for low flow vascular malformations.
-
Antenatal care and screening is an essential part of maternity care for all women. We provide state-of-the-art ultrasound screening, specialist obstetric and midwifery clinics.
-
Patient information leaflet for Functional Electrical Stimulation (FES) Clinic
-
If your doctor has referred you for a blood test, please book your phlebotomy (blood test) appointment online in advance.
-
This page is aimed at providing guidance and recommendations for patients, carers or family members following a high dose examination or procedure performed in the Neuroradiology department at NHNN, which involved ionising radiation.
-
Information on the different ways you can travel to University College London Hospitals (UCLH) if you don’t qualify for patient transport. It also includes advice on financial support that may be available to you.
-
This page contains information for patients (and their family and carers) who are considering having ablation for a liver tumour.
-
This page contains information for patients (and their family and carers) who are considering having ablation for a lung tumour.
-
Irreversible Electroporation for Prostate Cancer (IRE or Nanoknife™) patient information page.
-
Information about energy conservation for UCLH patients with mitochondrial disease.
File results
-
FOI/2022/0114 - Number of new diagnoses relating to various conditions
-
FOI/2022/0115 - Patient feeding and retail catering
-
FOI/2022/0119 - Chemotherapy for patients with osteosarcoma
-
FOI/2022/0123 - Sexual assault allegations in care settings
-
FOI/2022/0124 - Clinical service incidents caused by estates and infrastructure failure
-
FOI/2022/0127 - Provision for treatment of Functional Neurological Disorder (FND)
-
FOI/2022/0134 - Plastic laminating pouches/ sleeves purchased
-
FOI/2022/0140 - Early neo-natal deaths and babies born with serious brain injury
-
FOI/2022/0141 - Idiopathic pulmonary fibrosis (IPF) quality standard
-
FOI/2022/0145 - Head and neck cancer drug treatments